Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
Journal of Clinical Oncology.
Times cited: 36
- Radiolabeled J591 antibody delivers lethal hit to advanced prostate cancers in a Phase I trial. Cancer Biology and Therapy. 2004 Comment
Targeted Systemic Therapy of Prostate Cancer With a Monoclonal Antibody to Prostate-Specific Membrane Antigen.
Seminars in Oncology.
Times cited: 117